• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

显色mRNA原位杂交表达与LMO2蛋白和基因表达相关,并揭示其对弥漫性大B细胞淋巴瘤(NOS)生存的影响。

Chromogenic mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS.

作者信息

Papaleo Natalia, Molina-Alvarez Andrea, Onieva Ricard, Fuertes Diana, Sanchez-Gonzalez Blanca, Riera Xenia, Lopez-Segura David, Lome-Maldonado Carmen, Ara-Mancebo Xavier, Yelamos Jose, Salido Marta, Vazquez Ivonne, Calvo Xavier, Colomo Luis

机构信息

Department of Pathology, Hospital del Mar, Hospital del Mar Research Institute-IMIM, 08003 Barcelona, Spain.

Department of Pathology, Consorci Hospitalari Parc Tauli, Institut d'Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain.

出版信息

Cancers (Basel). 2024 Jun 28;16(13):2378. doi: 10.3390/cancers16132378.

DOI:10.3390/cancers16132378
PMID:39001439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11240605/
Abstract

BACKGROUND

is a relevant gene involved in B-cell ontogeny and a survival predictor of aggressive large B-cell lymphomas (aLBCL). Most studies assessing mRNA expression have relied on microarray platforms or qRT-PCR methods, overlooking tissue morphology. In this study, we evaluate RNA expression by chromogenic in situ hybridization (CISH) in normal tissue and in a series of 82 aLBCL.

METHODS

CISH was performed in formalin-fixed paraffin-embedded tissues, scored by three different methods, and correlated with a transcriptome panel.

RESULTS

We obtained statistically significant results correlating the methods of evaluation with LMO2 protein expression and gene expression results. Normal tonsil tissue showed high levels of , particularly within the light zone of the germinal center. Conversely, in aLBCL, a notable reduction in expression was noted, remarkably in cases carrying rearrangements. Furthermore, significant results were obtained through overall survival and Cox regression survival analysis, incorporating International Prognostic Index data alongside expression levels.

CONCLUSIONS

We show a reliable method to identify mRNA expression by CISH, effectively capturing many of the reported biologic features of LMO2.

摘要

背景

是一个与B细胞个体发育相关的基因,也是侵袭性大B细胞淋巴瘤(aLBCL)的生存预测指标。大多数评估mRNA表达的研究都依赖于微阵列平台或qRT-PCR方法,而忽略了组织形态学。在本研究中,我们通过显色原位杂交(CISH)评估正常组织和一系列82例aLBCL中的RNA表达。

方法

在福尔马林固定石蜡包埋组织中进行CISH,采用三种不同方法评分,并与转录组面板相关联。

结果

我们获得了具有统计学意义的结果,将评估方法与LMO2蛋白表达和基因表达结果相关联。正常扁桃体组织显示高水平的,特别是在生发中心的亮区。相反,在aLBCL中,观察到表达明显降低,在携带重排的病例中尤为明显。此外,通过总生存和Cox回归生存分析获得了显著结果,纳入了国际预后指数数据以及表达水平。

结论

我们展示了一种通过CISH识别mRNA表达的可靠方法,有效捕捉了许多已报道的LMO2生物学特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/b8ffd15cb5f3/cancers-16-02378-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/8cb0ee4f2292/cancers-16-02378-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/19c5a3f08ad4/cancers-16-02378-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/973dfb9d3ff7/cancers-16-02378-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/b8ffd15cb5f3/cancers-16-02378-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/8cb0ee4f2292/cancers-16-02378-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/19c5a3f08ad4/cancers-16-02378-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/973dfb9d3ff7/cancers-16-02378-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea8/11240605/b8ffd15cb5f3/cancers-16-02378-g004a.jpg

相似文献

1
Chromogenic mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS.显色mRNA原位杂交表达与LMO2蛋白和基因表达相关,并揭示其对弥漫性大B细胞淋巴瘤(NOS)生存的影响。
Cancers (Basel). 2024 Jun 28;16(13):2378. doi: 10.3390/cancers16132378.
2
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas.LMO2检测对侵袭性大B细胞淋巴瘤诊断的临床意义
Cancers (Basel). 2020 Apr 5;12(4):884. doi: 10.3390/cancers12040884.
3
LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.LMO2阴性表达可预测侵袭性B细胞淋巴瘤中MYC易位的存在。
Am J Surg Pathol. 2017 Jul;41(7):877-886. doi: 10.1097/PAS.0000000000000839.
4
Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas.Kappa 和 lambda 轻链 mRNA 原位杂交与流式细胞术和免疫组化在 B 细胞淋巴瘤中的比较。
Diagn Pathol. 2014 Jul 21;9:144. doi: 10.1186/1746-1596-9-144.
5
High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.LMO2在霍奇金淋巴瘤、伯基特淋巴瘤和生发中心弥漫性大B细胞淋巴瘤中高表达。
J Egypt Natl Canc Inst. 2011 Dec;23(4):147-53. doi: 10.1016/j.jnci.2011.10.006. Epub 2011 Dec 9.
6
Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score.弥漫性大B细胞淋巴瘤福尔马林固定石蜡包埋组织切片的qRT-PCR分析方案:六基因预测评分的验证
Oncotarget. 2016 Dec 13;7(50):83319-83329. doi: 10.18632/oncotarget.13066.
7
LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.LMO2 表达反映了 B 细胞急性淋巴细胞白血病中 blast 成熟的不同阶段和遗传特征,并预测临床结局。
Haematologica. 2011 Jul;96(7):980-6. doi: 10.3324/haematol.2011.040568. Epub 2011 Apr 1.
8
Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas.LMO2 克隆 SP51 表达缺失可识别侵袭性大 B 细胞淋巴瘤中的 MYC 重排。
Virchows Arch. 2021 Dec;479(6):1073-1078. doi: 10.1007/s00428-021-03091-9. Epub 2021 Apr 3.
9
The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.癌蛋白LMO2在正常生发中心B细胞和人类B细胞淋巴瘤中表达。
Blood. 2007 Feb 15;109(4):1636-42. doi: 10.1182/blood-2006-08-039024. Epub 2006 Oct 12.
10
Chromogenic In Situ Hybridization (CISH) as a Method for Detection of C-Myc Amplification in Formalin-Fixed Paraffin-Embedded Tumor Tissue: An Update.显色原位杂交(CISH)作为检测福尔马林固定石蜡包埋肿瘤组织中 C-Myc 扩增的方法:更新。
Methods Mol Biol. 2021;2318:313-320. doi: 10.1007/978-1-0716-1476-1_17.

引用本文的文献

1
Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas.联合免疫组化谱CD10/LMO2/MYC是筛查侵袭性大B细胞淋巴瘤中MYC重排的有用工具。
Virchows Arch. 2025 May;486(5):951-959. doi: 10.1007/s00428-024-03945-y. Epub 2024 Oct 22.

本文引用的文献

1
An atlas of cells in the human tonsil.人类扁桃体细胞图谱。
Immunity. 2024 Feb 13;57(2):379-399.e18. doi: 10.1016/j.immuni.2024.01.006. Epub 2024 Jan 31.
2
Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma.采用 LMO2 和 MYC 免疫组化标记的轮替检测法筛选侵袭性大 B 细胞淋巴瘤中的 MYC 重排。
Virchows Arch. 2024 Aug;485(2):307-314. doi: 10.1007/s00428-023-03584-9. Epub 2023 Jun 27.
3
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.
弥漫性大 B 细胞淋巴瘤真实世界人群中临床结局的分子决定因素。
Blood. 2023 May 18;141(20):2493-2507. doi: 10.1182/blood.2022018248.
4
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版:淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
5
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.成熟淋巴细胞肿瘤国际共识分类:临床咨询委员会报告。
Blood. 2022 Sep 15;140(11):1229-1253. doi: 10.1182/blood.2022015851.
6
LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage.LMO2 表达在 T 淋巴母细胞白血病中频繁出现,与生存相关,而与 T 细胞阶段无关。
Mod Pathol. 2022 Sep;35(9):1220-1226. doi: 10.1038/s41379-022-01063-1. Epub 2022 Mar 23.
7
Low LIM-domain only 2 (LMO2) expression in aggressive B cell lymphoma correlates with and / rearrangements, especially in germinal center cell-type tumors.低仅含LIM结构域2(LMO2)在侵袭性B细胞淋巴瘤中的表达与 及 / 重排相关,尤其在生发中心细胞型肿瘤中。 (注:原文中“ and / rearrangements”部分表述不完整,可能影响准确理解,但按要求完整翻译了现有内容)
Leuk Lymphoma. 2021 Oct;62(10):2547-2550. doi: 10.1080/10428194.2021.1927020. Epub 2021 May 14.
8
Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas.LMO2 克隆 SP51 表达缺失可识别侵袭性大 B 细胞淋巴瘤中的 MYC 重排。
Virchows Arch. 2021 Dec;479(6):1073-1078. doi: 10.1007/s00428-021-03091-9. Epub 2021 Apr 3.
9
Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas.LMO2检测对侵袭性大B细胞淋巴瘤诊断的临床意义
Cancers (Basel). 2020 Apr 5;12(4):884. doi: 10.3390/cancers12040884.
10
A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma.LMO2 阴性和 CD38 阳性的组合对 Burkitt 淋巴瘤的诊断有用。
Diagn Pathol. 2019 Sep 4;14(1):100. doi: 10.1186/s13000-019-0876-3.